Company Description

Mesintel has developed a proprietary target discovery platform that incorporates our extensive knowledge of fibroblast biology to accelerate the development of therapeutics in areas of high unmet medical need, including cancer and fibrosis. They are also leveraging their platform in complementary therapeutic areas, such as rare diseases, tissue regeneration and aging.